Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Highbridge_Capital_Management
|
| gptkbp:CEO |
John Sedor
|
| gptkbp:filedForBankruptcy |
2019
|
| gptkbp:foundedYear |
1996
|
| gptkbp:headquartersLocation |
gptkb:Morristown,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pernix Therapeutics
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Zohydro_ER
Sildec PE Trezix Tussionex |
| gptkbp:products |
over-the-counter drugs
prescription drugs |
| gptkbp:tradedOn |
NASDAQ: PTX
|
| gptkbp:website |
www.pernixtx.com
|
| gptkbp:bfsParent |
gptkb:Silenor
gptkb:PNT2001 |
| gptkbp:bfsLayer |
8
|